The Role of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.

Researchers reviewed the connection between heart failure with preserved ejection fraction (HFpEF) and problems with tiny blood vessels in the heart called coronary microvascular dysfunction (CMD). HFpEF affects about 32 million people worldwide and occurs when the heart pumps normally but doesn't relax properly between beats, causing symptoms like shortness of breath and fatigue. The study found that up to 75% of HFpEF patients have CMD, even when their larger heart arteries appear normal. People with both conditions face higher risks of hospitalization and death, yet CMD often goes undiagnosed. The review examined how these small blood vessel problems may actually cause or worsen heart failure by reducing blood flow and oxygen delivery to heart muscle. Understanding this connection could lead to better treatments targeting the microvascular system. For patients with HFpEF considering complementary therapies like acupuncture, this research highlights the importance of addressing underlying cardiovascular health. While acupuncture has shown promise for some cardiovascular conditions by potentially improving blood flow and reducing inflammation, patients with HFpEF should discuss any complementary approaches with their cardiologist to ensure they complement conventional medical management. The complex nature of HFpEF requires careful coordination of all therapies. If exploring acupuncture as part of a comprehensive care plan, seek a licensed acupuncturist experienced in treating patients with cardiovascular conditions.

This review examines coronary microvascular dysfunction (CMD) as a pathophysiologic driver in heart failure with preserved ejection fraction (HFpEF), affecting approximately 32 million patients globally. Key findings demonstrate CMD prevalence reaches 75% in HFpEF patients without obstructive epicardial disease, correlating with increased rehospitalization and mortality rates. The review synthesizes evidence linking microvascular endothelial dysfunction, impaired vasodilation, and reduced coronary flow reserve to HFpEF development and progression. No original study methodology or sample sizes were reported as this was a literature review. Clinical significance centers on CMD's underdiagnosis despite its prognostic implications. The authors emphasize that understanding HFpEF-CMD pathophysiologic connections may inform targeted therapeutic strategies. For acupuncture practitioners, this underscores the importance of recognizing cardiovascular complexity in patients presenting with fatigue and exercise intolerance, warranting careful intake assessment and appropriate medical co-management when treating individuals with known or suspected HFpEF.